Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer

Christopher B Umbricht, Ella Evron, Edward Gabrielson, Anne Ferguson, Jeffrey Marks, Saraswati Sukumar

Research output: Contribution to journalArticle

Abstract

We have identified 14-3-3 σ (σ) as a gene whose expression is lost in breast carcinomas, primarily by methylation-mediated silencing. In this report, we investigated the timing of loss of σ gene expression during breast tumorigenesis in vivo. We analysed the methylation status of σ in breast cancer precursor lesions using microdissection for selective tissue sampling. We found hypermethylation of σ in 24 of 25 carcinomas (96%), 15 of 18 (83%) of ductal carcinoma in situ, and three of eight (38%) of atypical hyperplasias. None of the five hyperplasias without atypia showed σ-hypermethylation. Unexpectedly, patients with breast cancer showed σ hypermethylation in adjacent histologically normal breast epithelium, while this was never observed in individuals without evidence of breast cancer. Also, samples of periductal stromal breast tissue were consistently hypermethylated, underscoring the importance of selective tissue sampling for accurate assessment of 14-3-3-σ methylation in breast epithelium. These results suggest that hypermethylation of 14-3-3-σ occurs at an early stage in the progression to invasive breast cancer, and may occur in apparently normal epithelium adjacent to breast cancer. These results provide evidence that loss of expression of σ is an early event in neoplastic transformation.

Original languageEnglish (US)
Pages (from-to)3348-3353
Number of pages6
JournalOncogene
Volume20
Issue number26
DOIs
StatePublished - Jun 7 2001

Fingerprint

Breast Neoplasms
Breast
Methylation
Epithelium
Hyperplasia
Gene Expression
Microdissection
Carcinoma, Intraductal, Noninfiltrating
Carcinogenesis
Carcinoma

Keywords

  • 14-3-3 σ
  • Breast cancer
  • DCIS
  • Methylation
  • MSP
  • Preneoplasia

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer. / Umbricht, Christopher B; Evron, Ella; Gabrielson, Edward; Ferguson, Anne; Marks, Jeffrey; Sukumar, Saraswati.

In: Oncogene, Vol. 20, No. 26, 07.06.2001, p. 3348-3353.

Research output: Contribution to journalArticle

@article{d64de80121ec4579a095f1b6bce8683f,
title = "Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer",
abstract = "We have identified 14-3-3 σ (σ) as a gene whose expression is lost in breast carcinomas, primarily by methylation-mediated silencing. In this report, we investigated the timing of loss of σ gene expression during breast tumorigenesis in vivo. We analysed the methylation status of σ in breast cancer precursor lesions using microdissection for selective tissue sampling. We found hypermethylation of σ in 24 of 25 carcinomas (96{\%}), 15 of 18 (83{\%}) of ductal carcinoma in situ, and three of eight (38{\%}) of atypical hyperplasias. None of the five hyperplasias without atypia showed σ-hypermethylation. Unexpectedly, patients with breast cancer showed σ hypermethylation in adjacent histologically normal breast epithelium, while this was never observed in individuals without evidence of breast cancer. Also, samples of periductal stromal breast tissue were consistently hypermethylated, underscoring the importance of selective tissue sampling for accurate assessment of 14-3-3-σ methylation in breast epithelium. These results suggest that hypermethylation of 14-3-3-σ occurs at an early stage in the progression to invasive breast cancer, and may occur in apparently normal epithelium adjacent to breast cancer. These results provide evidence that loss of expression of σ is an early event in neoplastic transformation.",
keywords = "14-3-3 σ, Breast cancer, DCIS, Methylation, MSP, Preneoplasia",
author = "Umbricht, {Christopher B} and Ella Evron and Edward Gabrielson and Anne Ferguson and Jeffrey Marks and Saraswati Sukumar",
year = "2001",
month = "6",
day = "7",
doi = "10.1038/sj.onc.1204438",
language = "English (US)",
volume = "20",
pages = "3348--3353",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "26",

}

TY - JOUR

T1 - Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer

AU - Umbricht, Christopher B

AU - Evron, Ella

AU - Gabrielson, Edward

AU - Ferguson, Anne

AU - Marks, Jeffrey

AU - Sukumar, Saraswati

PY - 2001/6/7

Y1 - 2001/6/7

N2 - We have identified 14-3-3 σ (σ) as a gene whose expression is lost in breast carcinomas, primarily by methylation-mediated silencing. In this report, we investigated the timing of loss of σ gene expression during breast tumorigenesis in vivo. We analysed the methylation status of σ in breast cancer precursor lesions using microdissection for selective tissue sampling. We found hypermethylation of σ in 24 of 25 carcinomas (96%), 15 of 18 (83%) of ductal carcinoma in situ, and three of eight (38%) of atypical hyperplasias. None of the five hyperplasias without atypia showed σ-hypermethylation. Unexpectedly, patients with breast cancer showed σ hypermethylation in adjacent histologically normal breast epithelium, while this was never observed in individuals without evidence of breast cancer. Also, samples of periductal stromal breast tissue were consistently hypermethylated, underscoring the importance of selective tissue sampling for accurate assessment of 14-3-3-σ methylation in breast epithelium. These results suggest that hypermethylation of 14-3-3-σ occurs at an early stage in the progression to invasive breast cancer, and may occur in apparently normal epithelium adjacent to breast cancer. These results provide evidence that loss of expression of σ is an early event in neoplastic transformation.

AB - We have identified 14-3-3 σ (σ) as a gene whose expression is lost in breast carcinomas, primarily by methylation-mediated silencing. In this report, we investigated the timing of loss of σ gene expression during breast tumorigenesis in vivo. We analysed the methylation status of σ in breast cancer precursor lesions using microdissection for selective tissue sampling. We found hypermethylation of σ in 24 of 25 carcinomas (96%), 15 of 18 (83%) of ductal carcinoma in situ, and three of eight (38%) of atypical hyperplasias. None of the five hyperplasias without atypia showed σ-hypermethylation. Unexpectedly, patients with breast cancer showed σ hypermethylation in adjacent histologically normal breast epithelium, while this was never observed in individuals without evidence of breast cancer. Also, samples of periductal stromal breast tissue were consistently hypermethylated, underscoring the importance of selective tissue sampling for accurate assessment of 14-3-3-σ methylation in breast epithelium. These results suggest that hypermethylation of 14-3-3-σ occurs at an early stage in the progression to invasive breast cancer, and may occur in apparently normal epithelium adjacent to breast cancer. These results provide evidence that loss of expression of σ is an early event in neoplastic transformation.

KW - 14-3-3 σ

KW - Breast cancer

KW - DCIS

KW - Methylation

KW - MSP

KW - Preneoplasia

UR - http://www.scopus.com/inward/record.url?scp=0035821727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035821727&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1204438

DO - 10.1038/sj.onc.1204438

M3 - Article

C2 - 11423985

AN - SCOPUS:0035821727

VL - 20

SP - 3348

EP - 3353

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 26

ER -